Hybrigenics
Hybrigenics offers a bioinformatics platforms to identify;validate;and inhibit protein interactions to develop therapeutics for cancer.
Total raised
€13M
€13,388,000
Funding rounds
2
Investors
0
distinct backers
Active since
2009-08
latest 2017-07
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-08-01 | Other | €6.8M | — | View deal → |
| 2009-09-01 | Other | €6.6M | — | View deal → |
Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software